Welcome, Guest. Please login or register.

Author Topic: AtheroGenics Announces Encouraging Interim Results From Phase 3 Clinical Trial of AGI-1067 in Type 2 Diabetes  (Read 936 times)

0 Members and 1 Guest are viewing this topic.

The Web Team

  • Hero Member
  • *****
  • Posts: 8755
  • Karma: 14
    • View Profile
    • Qwoter
AtheroGenics Announces Encouraging Interim Results From Phase 3 Clinical Trial of AGI-1067 in Type 2 Diabetes
           


Company to Host Conference Call and Webcast on April 14, 2008 at 9 a.m. EDT
           

http://www.marketwire.com/mw/release.do?id=843188&sourceType=3
           
The Web Team
Qwoter.com

Tags:
 

Related Topics

  Subject / Started by Replies Last post
0 Replies
894 Views
Last post October 23, 2007, 09:00:33 AM
by The Web Team
0 Replies
1004 Views
Last post December 03, 2007, 08:00:44 AM
by The Web Team
1 Replies
4644 Views
Last post December 04, 2007, 11:11:57 AM
by Deez
0 Replies
777 Views
Last post February 01, 2008, 09:01:05 AM
by The Web Team
0 Replies
947 Views
Last post February 07, 2008, 07:00:51 AM
by The Web Team
0 Replies
874 Views
Last post February 26, 2008, 09:00:55 AM
by The Web Team
0 Replies
920 Views
Last post July 08, 2008, 03:08:38 PM
by The Web Team
0 Replies
1036 Views
Last post July 14, 2008, 03:10:46 PM
by The Web Team
0 Replies
929 Views
Last post July 31, 2008, 06:12:07 AM
by The Web Team
0 Replies
398 Views
Last post March 12, 2014, 07:10:14 PM
by MTnews